Internal Medicine · Forest Hills, NY
NPI
1710936232
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
107-21 Queens Blvd Suite #6
Forest Hills, NY, 11375
Phone (718) 261-2992
Groups this clinician bills Medicare through
Medicare paid, 2024
$900K
13,232 services
Medicare patients, 2024
1,070
Average age 80
Drug cost, 2024
$5.0M
30,411 prescriptions
Company payments, 2025
$978
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Tavdy was code 99308 (snf e&m), 3,629 times for 258 patients. In total David Tavdy billed 13,232 services in 50 codes, and Medicare paid $900K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 3,629 | 258 | $58.72 | $213K |
| 99232 Hospital E&M - Subsequent | Facility | 2,571 | 396 | $61.98 | $159K |
| 99308 SNF E&M | Facility | 1,926 | 219 | $58.11 | $112K |
| 99309 SNF E&M | Office | 795 | 193 | $85.48 | $68K |
| 99309 SNF E&M | Facility | 679 | 167 | $83.96 | $57K |
| 99213 Office E&M - Established | Office | 467 | 155 | $65.45 | $31K |
| 99223 Hospital E&M - Initial | Facility | 378 | 286 | $135.88 | $51K |
| 99238 Hospital Discharge Management | Facility | 361 | 274 | $63.89 | $23K |
| 99348 Home E&M - New and Established | Office | 270 | 32 | $56.92 | $15K |
| 99214 Office E&M - Established | Office | 215 | 114 | $96.68 | $21K |
| 99291 Critical Care E&M | Facility | 210 | 43 | $167.45 | $35K |
| 99306 SNF E&M | Facility | 183 | 160 | $143.87 | $26K |
| 36415 Venipuncture Blood Collection | Office | 160 | 113 | $8.65 | $1,384 |
| 99316 SNF E&M | Facility | 131 | 118 | $102.22 | $13K |
| 99306 SNF E&M | Office | 129 | 108 | $143.88 | $19K |
By year: 2022 $942K for 12,706 services; 2023 $970K for 13,428 services; 2024 $900K for 13,232 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 160 | 113 | $8.65 | $1,384 |
Medicare prescription drug claims, 2024
In 2024, the drug David Tavdy prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,460 prescriptions and refills. In total David Tavdy wrote 30,411 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,460 | 1,861 | 275 | $17K |
| Amlodipine Besylate Generic | 1,233 | 1,572 | 213 | $7,277 |
| Eliquis Apixaban | 825 | 838 | 121 | $333K |
| Levothyroxine Sodium Generic | 775 | 1,005 | 129 | $8,459 |
| Furosemide Generic | 696 | 772 | 123 | $3,315 |
| Gabapentin Generic | 674 | 744 | 121 | $7,830 |
| Losartan Potassium Generic | 674 | 843 | 115 | $4,760 |
| Mirtazapine Generic | 625 | 641 | 87 | $12K |
| Tamsulosin Hcl Generic | 607 | 709 | 112 | $8,483 |
| Metformin Hcl Generic | 575 | 777 | 132 | $28K |
| Metoprolol Tartrate Generic | 559 | 614 | 89 | $4,399 |
| Famotidine Generic | 522 | 574 | 74 | $17K |
| Metoprolol Succinate Generic | 461 | 607 | 101 | $6,679 |
| Escitalopram Oxalate Generic | 425 | 481 | 54 | $4,925 |
| Rosuvastatin Calcium Generic | 411 | 497 | 79 | $4,810 |
Brand drugs: 6,791 claims; generic drugs: 22,818 claims; opioid claims: 257.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Tavdy $978 ($978 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $167.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $154 |
| Lilly USA, LLC LLY | 4 | $111 |
| Amgen Inc. AMGN | 4 | $94.95 |
| Ardelyx, Inc. ARDX | 3 | $90.87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $89.19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $64.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56.35 |
| Aimmune Therapeutics, Inc. | 2 | $45.03 |
| Astellas Pharma US Inc 4503.T | 1 | $33.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.